20/20 Biolabs, Inc. Nonoperating Income (Expense)
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-14
- 20/20 Biolabs, Inc. nonoperating income (expense) for the quarter ending 2026-06-30 was -$262.12K, a 5632.29% decline year-over-year.
- 20/20 Biolabs, Inc. nonoperating income (expense) for the quarter ending 2026-03-31 was -$731.48K, a 9720.94% decline year-over-year.
- 20/20 Biolabs, Inc. nonoperating income (expense) for the quarter ending 2025-06-30 was $4.74K.
- 20/20 Biolabs, Inc. nonoperating income (expense) for the quarter ending 2025-03-31 was $7.60K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|
| 2026-06-30 | -$262.12K 10-Q · filed 2026-08-14 | -$993.60K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$731.48K 10-Q · filed 2026-05-20 | ||
| 2025-12-31 | -$407.95K POS AM · filed 2026-04-06 | ||
| 2025-06-30 | $4.74K 10-Q · filed 2026-08-14 | $12.34K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $7.60K 10-Q · filed 2026-05-20 | ||
| 2024-12-31 | $125.75K POS AM · filed 2026-04-06 |